drugset / Trial / NCT06719934

Ttt of Adenomyosis

NCT06719934

Phase 1 Not yet recruiting 100 enrolled Al-Azhar University
RandomizedParallel-groupSingle-blindTreatment

Summary

to evaluate use of Dienogest versus uterine arteries embolization in treatment of Adenomyosis-associated symptoms as dysmenorrhea, heavy menstrual bleeding and bulk-related symptoms

Timeline

Start
2025-01-01
Primary completion
2025-06-01
Completion
2026-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dienogest Small molecule 2 mg Oral

Indications